Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | 0.027 | 1 | 0.5 |
Leishmania major | S-adenosylhomocysteine hydrolase | 0.027 | 1 | 1 |
Mycobacterium leprae | putative S-adenosyl-L-homocysteine hydrolase SahH | 0.027 | 1 | 1 |
Schistosoma mansoni | adenosine deaminase | 0.0169 | 0.4538 | 0.0168 |
Trypanosoma brucei | S-adenosylhomocysteine hydrolase, putative | 0.027 | 1 | 0.5 |
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | 0.027 | 1 | 0.5 |
Treponema pallidum | adenosine deaminase | 0.0169 | 0.4538 | 0.5 |
Schistosoma mansoni | adenosylhomocysteinase | 0.027 | 1 | 1 |
Entamoeba histolytica | adenosylhomocysteinase, putative | 0.027 | 1 | 1 |
Schistosoma mansoni | adenosine deaminase-related | 0.0169 | 0.4538 | 0.0168 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.0169 | 0.4538 | 0.5 |
Plasmodium vivax | adenosylhomocysteinase(S-adenosyl-L-homocystein e hydrolase), putative | 0.027 | 1 | 1 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.027 | 1 | 1 |
Mycobacterium tuberculosis | Probable adenosylhomocysteinase SahH (S-adenosyl-L-homocysteine hydrolase) (adohcyase) | 0.027 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.4538 | 0.3521 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0169 | 0.4538 | 0.4538 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0169 | 0.4538 | 0.4538 |
Echinococcus granulosus | adenosylhomocysteinase | 0.027 | 1 | 1 |
Mycobacterium ulcerans | S-adenosyl-L-homocysteine hydrolase | 0.027 | 1 | 1 |
Toxoplasma gondii | adenosylhomocysteinase, putative | 0.027 | 1 | 1 |
Loa Loa (eye worm) | adenosylhomocysteinase | 0.027 | 1 | 1 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.027 | 1 | 1 |
Toxoplasma gondii | S-Adenosyl homocysteine hydrolase | 0.027 | 1 | 1 |
Plasmodium falciparum | adenosylhomocysteinase | 0.027 | 1 | 1 |
Echinococcus multilocularis | adenosylhomocysteinase | 0.027 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.